Myanmar Healthcare Monthly: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Myanmar Healthcare Monthly.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on November 14, 2025

November 14, 2025

Fortress Biotech Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

GlobeNewswire

November 14, 2025

AEON Biopharma Reports Third Quarter 2025 Results, Including Positive ABP-450 Biosimilarity Data and Strategic Positioning for Continued Growth

GlobeNewswire

November 14, 2025

IO Biotech Reports Third Quarter 2025 Financial Results and Provides Business Highlights

GlobeNewswire

November 14, 2025

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

November 14, 2025

Galectin Therapeutics Reports Financial Results for the quarter ended September 30, 2025, and Provides Business Update

GlobeNewswire

November 14, 2025

CG Oncology Reports Third Quarter 2025 Financial Results and Provides Business Updates

GlobeNewswire

November 14, 2025

Cogent Biosciences Announces Participation in the Jefferies Global Healthcare Conference

GlobeNewswire

November 14, 2025

Nanox Partners with French Radiology Group Olympe Imagerie to Advance Clinical Validation in Europe

GlobeNewswire

November 14, 2025

Cocrystal Pharma Reports Third Quarter 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs

GlobeNewswire

November 14, 2025

Paragon Genomics Introduces New CleanPlex® NGS Panel for Pharmacogenomics Profiling at AMP 2025

GlobeNewswire

November 14, 2025

Lifeward Ltd. Reports Third Quarter 2025 Financial Results

GlobeNewswire

November 14, 2025

Sensei Biotherapeutics Reports Third Quarter 2025 Financial Results

GlobeNewswire

November 14, 2025

Anavex Life Sciences Provides Regulatory Update on Blarcamesine for Early Alzheimer's Disease

GlobeNewswire

November 14, 2025

MiNK Therapeutics Reports Q3 2025 Results and Accelerates iNKT Platform Toward Pivotal Development Across Oncology, Pulmonary Disease, and Transplantation

GlobeNewswire

November 14, 2025

Coave Therapeutics unveils lead gene therapy program for retinal vascular diseases, powered by first-in-class vector for suprachoroidal delivery

GlobeNewswire

November 14, 2025

Marker Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates

GlobeNewswire

November 14, 2025

Mersana Therapeutics Provides Business Update and Announces Third Quarter 2025 Financial Results

GlobeNewswire

November 14, 2025

New Data Confirms Performance of DecisionDx®-Melanoma to Identify Patients with Less Than Five Percent Risk of Sentinel Lymph Node Positivity

GlobeNewswire

November 14, 2025

Picard Reports Third Quarter 2025 Financial Results

GlobeNewswire

November 14, 2025

Communiqué de presse : Teizeild, un médicament Sanofi, a reçu l’approbation du CHMP pour une autorisation de mise sur le marché dans l’UE chez les patients atteints de diabète de type 1 de stade 2

GlobeNewswire